Oak Ridge Investments’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$835K Buy
56,112
+37,302
+198% +$402K 0.05% 131
2026
Q1
$159K Buy
18,810
+3,164
+20% +$34.6K 0.01% 181
2025
Q4
$177K Sell
15,646
-3,413
-18% -$42.3K 0.01% 178
2025
Q3
$286K Sell
19,059
-187
-1% -$2.72K 0.02% 166
2025
Q2
$272K Sell
19,246
-1,118
-5% -$19.9K 0.02% 162
2025
Q1
$490K Sell
20,364
-107
-0.5% -$3.77K 0.04% 140
2024
Q4
$765K Sell
20,471
-675
-3% -$31.5K 0.06% 126
2024
Q3
$1.06M Sell
21,146
-854
-4% -$33.2K 0.09% 108
2024
Q2
$764K Buy
22,000
+14,607
+198% +$578K 0.07% 124
2024
Q1
$404K Sell
7,393
-409
-5% -$20.3K 0.04% 138
2023
Q4
$334K Sell
7,802
-635
-8% -$19.7K 0.04% 142
2023
Q3
$219K Sell
8,437
-302
-3% -$6.28K 0.03% 140
2023
Q2
$209K Buy
+8,739
New +$150K 0.03% 146

Other funds holding BHVN

Oak Ridge Investments's BHVN Position: Q2 2026 in Review

Oak Ridge Investments increased its Biohaven (BHVN) stake by 198% in Q2 2026, buying an estimated $402K and bringing the position to 56,112 shares worth $835K. The position accounts for 0.05% of the portfolio, ranked #131.

Oak Ridge Investments first reported a position in BHVN in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.06M in Q3 2024. 41 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Oak Ridge Investments held 56,112 shares of Biohaven worth $835K as of Q2 2026.
  • Oak Ridge Investments bought 37,302 Biohaven shares in Q2 2026, an estimated $402K.
  • Biohaven made up 0.05% of Oak Ridge Investments's portfolio in Q2 2026, its #131 holding.
  • Oak Ridge Investments first reported a position in Biohaven in Q2 2023 and has held it in 13 quarters since.
  • Oak Ridge Investments's Biohaven position peaked at $1.06M in Q3 2024.
  • 41 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Oak Ridge Investments's 13F filing for Q2 2026, filed 21 Jul 2026.